Distalmotion has made its first sale of a number of surgical robots within the U.S. AdventHealth, which operates 50 hospitals in 9 states, has chosen Distalmotion’s DEXTER system to assist the expansion of minimally invasive procedures. It has already accomplished its first circumstances with the system.
“We’re excited to have accomplished our first circumstances with DEXTER as we convey robotic surgical procedure to our outpatient division,” stated Dr. Carlos Ortiz-Ortiz M.D., FACS, common surgeon at AdventHealth Celebration. “As we develop our capabilities, we’re centered on options that align with our objectives for flexibility and effectivity.”
DEXTER is designed to simplify operations and widen entry to robotic surgical procedure worldwide, in accordance with Distalmotion. The Lausanne, Switzerland-based firm gives its expertise to hospital outpatient departments (HOPDs) and ambulatory surgical facilities (ASCs). Distalmotion, which has U.S. places of work in Cleveland, stated DEXTER is commercially out there within the U.S. and Europe.
DEXTER designed for flexibility
Demand for surgical robotics continues to rise, and extra high-volume soft-tissue procedures—equivalent to inguinal hernia restore and cholecystectomy—are transferring into outpatient settings. In response, healthcare amenities are looking for options that match their medical and operational wants. Nonetheless, their deal with effectivity and affected person expertise makes present soft-tissue robots impractical as a consequence of dimension, operational complexity, and prices, stated Distalmotion.
The corporate stated it designed DEXTER to be cell and sufficiently small to be simply moved between working rooms (ORs), arrange rapidly, and built-in into present procedures. It might scale back turnover time, maximize throughput, and enhance the variety of sufferers who profit from minimally invasive care, stated Distalmotion.
The corporate claimed that DEXTER is the one system out there within the U.S. and European markets with each a sterile console and absolutely open structure. The sterile console permits surgeons to carry out bedside duties after which instantly return to operation and not using a change in sterility or redocking of the robotic.
The console retains the surgeon near the affected person, helps transitions between laparoscopic and robotic methods as desired, and enhances communication with OR groups, stated Distalmotion.
DEXTER’s open structure helps using most popular devices and OR applied sciences which might be already out there within the facility, minimizing the necessity to to buy pricey new applied sciences. DEXTER comes with a collection of absolutely wristed single-use robotic devices to boost dexterity and precision.
The structure permits compatibility with present and future OR applied sciences, together with visualization methods and superior gadgets, for cost-effective provide chain operations. Collectively, these options give surgeons the power to make use of workflows they imagine are finest for every affected person.
“This multi-system sale underscores how well being methods are looking for extra versatile options that convey the advantages of robotics to ORs throughout their websites of care,” acknowledged Greg Roche, CEO of Distalmotion. “DEXTER is designed to fulfill the realities of outpatient surgical procedure, with out compromising present practices.”
Distalmotion builds momentum in U.S. growth
The DEXTER Robotic Surgical procedure System is at present licensed just for use in inguinal hernia restore and cholecystectomy for adults 22 years previous and older within the U.S. In Europe, the robotic is meant to help within the correct management of laparoscopic surgical devices throughout urologic, common, and gynecologic procedures.
DEXTER has been concerned in additional than 2,000 procedures accomplished globally throughout common, gynecological, and urological specialties. Distalmotion stated stays centered on making robotic surgical procedure extra accessible throughout extra websites of care globally.
In March, the corporate stated it had accomplished its first U.S. sale and supply of DEXTER to Memorial Hermann Well being System. The built-in system serves Southeast Texas and the higher Houston neighborhood with greater than 270 care supply websites, together with 17 hospitals.
Later that month, it introduced that Northtowns ASC had chosen DEXTER for robotic outpatient surgical procedures.
This 12 months, Distalmotion additionally accomplished two research, the NEST research (NCT06473688) centered on cholecystectomy and the HYPER research (NCT06473675) pertaining to benign hysterectomy. Distalmotion has additionally initiated its sacrocolpopexy medical research, with the primary affected person enrolled in Q1 2025. The corporate stated these research will assist it higher meet the evolving wants of healthcare suppliers.
Editor’s word: This text is syndicated The Robotic Report sibling website MassDevice.